A world where a robot quickly scans your body for skin cancer or your forehead lines stay frozen with just a treatment or two ...

Chinese-based Innovent Biologics and HUTCHMED are eyeing approval for their cancer combination after a joint Phase II/III ...

FAP has long been a target for cancer therapy, but the development ... Hope et al, SNMMI Procedure Standard/EANM Practice Guideline for Fibroblast Activation Protein (FAP) PET, Journal of Nuclear ...

This unbiased approach allowed them to discover previously unknown methylation events that affect protein levels and drive cancer. One finding in particular caught Ding’s attention. Hypomethylation on ...

Stromal cells, which provide structural support to breast tissue, “downregulate fibroblast marker genes and upregulate markers of senescence and cancer-associated fibroblasts.” Immune cells ...

Dr. Sleeman has more than two decades of experience as an R&D leader and scientist in inflammatory disease and cancer. His career has encompassed the research and development of six FDA-approved ...

Telix Pharmaceuticals has wrapped up its acquisition of a suite of new theranostic candidates, targeting fibroblast ...

Cambridge biotech company Mestag Therapeutics has appointed experienced executive Dr Matthew Sleeman as Chief Scientific Officer. Mestag is harnessing fibroblast immunology for patients with ...